Blacktrace expands its presence in Japan with new office in Kanagawa
- Published in Source Clusters
Blacktrace has increased its presence in Japan by opening a new office in Kanagawa and doubling its sales team in order to help the company meet increasing demand for its product development services from the biology, chemistry and microfluidics sectors. The expansion increases the Japanese sales team’s ability to support customers working in the rapidly growing area of single-cell genomics: Blacktrace’s newest brand, Dolomite Bio, is a key technology provider in this field, where its Nadia Instrument is helping to accelerate disease research and drug discovery in areas such as oncology and neurology.
The microfluidics and flow chemistry markets are also experiencing year-on-year growth in Japan, and the company says the additional customer support will ensure that Blacktrace’s other brands, Dolomite Microfluidics and Syrris, will be well positioned to meet this demand. The new Japanese facility will also enable the company to host workshops and in-person meetings, solidifying relationships and providing stronger local support.
For further information about Blacktrace visit www.blacktrace.com
Related items
- TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products
- Almac Group extends personalised cancer vaccine production facilities
- Cobra Biologics appoints Dr Darrell Sleep as Director of Innovation
- Phico Therapeutics appoints financial director and two non-executive directors
- Evonetix appoints Stephanie Brooking as Head of Product Management
- Expedeon licenses Lightning-Link rapid biotinylation technology to Cell Guidance Systems
- Dolomite Bio maintains rapid growth trajectory, plans new product launches
- Ingenza’s Ian Fotheringham to present the Charles Tennant Memorial Lecture
- Leading cell culture media company changes name to FUJIFILM Irvine Scientific, Inc
- Evonetix establishes scientific advisory board
Latest from Tom Mulligan
- SGS’s first malaria human challenge trial will take place in Belgium this month
- TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products
- Horizon Discovery extends CRISPR Screening Service to primary human T cells
- TrakCel and The Quick Life Science Group partner on supply chain IT solution for cell and gene therapies
- Almac Group extends personalised cancer vaccine production facilities
- Cobra Biologics appoints Dr Darrell Sleep as Director of Innovation
- Phico Therapeutics appoints financial director and two non-executive directors
- Evonetix appoints Stephanie Brooking as Head of Product Management
- Bio-Rad publishes new findings on generation and characterisation of drug-target-complex-specific antibodies
- Expedeon licenses Lightning-Link rapid biotinylation technology to Cell Guidance Systems